Multicenter Phase II Study of XELOX with Bevacizumab in the Late Elderly Patients with Unresectable Advanced/Recurrent Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2618959
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: XELOX+BV regimen (Capecitabine, Oxaliplatin, Bevacizumab)
Primary outcome(s): Progression Free Survival
Study Design: Single arm Non-randomized
创建时间：
2010-05-15
